Division of Rheumatology, Centro Nacional de Enfermedades Reumáticas, Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela.
Rheumatol Int. 2011 May;31(5):657-65. doi: 10.1007/s00296-009-1358-9. Epub 2010 Jan 12.
A retrospective study in a hospital-based sample of Venezuelan patients with rheumatoid arthritis was made to estimate the lag time between onset of symptoms, diagnosis, and initiation of DMARD treatment. Medical records and in-person interview of patients to fill in a questionnaire collecting information on demographics and initiation of symptoms, first consultation with any physician, time of diagnosis, and initiation of first disease-modifying anti-rheumatic drug were reviewed. We performed descriptive statistics and multivariable linear regression analysis. Mean lag time between symptom onset and diagnosis of rheumatoid arthritis was 40.5 months (range 1-424). Mean lag time between onset of symptoms and first consultation with a physician and between first consultation and diagnosis was 16.3 and 23.9 months, respectively. Mean lag time between onset of symptoms and initiation of DMARD treatment was 56.9 months. A definitive diagnosis of rheumatoid arthritis was done by a rheumatologist in 251 patients (92.3%). First consultation with an orthopedist or a primary care physician, first consultation in a public versus a private health center, and diagnosis before 2000 were associated with longer lag time between onset of symptoms and diagnosis. Venezuelan patients with rheumatoid arthritis had a marked delay from disease onset to diagnosis and initiation of first DMARD. First consultation with an orthopedist and consultation in a public versus a private health center were the variables with the strongest effect on lag time to diagnosis and to initiation of first DMARD.
对委内瑞拉类风湿关节炎患者的医院样本进行回顾性研究,以估计症状发作、诊断和开始使用 DMARD 治疗之间的时间间隔。回顾了病历和对患者的面对面访谈,以填写一份收集人口统计学和症状开始、首次咨询任何医生、诊断时间和首次使用疾病修正抗风湿药物的信息的问卷。我们进行了描述性统计和多变量线性回归分析。从症状发作到类风湿关节炎诊断的平均时间间隔为 40.5 个月(范围 1-424)。从症状发作到首次咨询医生和首次咨询到诊断的平均时间间隔分别为 16.3 和 23.9 个月。从症状发作到开始使用 DMARD 治疗的平均时间间隔为 56.9 个月。251 名患者(92.3%)由风湿病专家做出明确的类风湿关节炎诊断。首次咨询骨科医生或初级保健医生、在公立还是私立医疗中心首次就诊以及 2000 年前的诊断与症状发作和诊断之间的时间间隔延长有关。委内瑞拉类风湿关节炎患者从疾病发作到诊断和开始使用第一种 DMARD 的时间明显延迟。首次咨询骨科医生和在公立与私立医疗中心就诊是对诊断和开始使用第一种 DMARD 的时间间隔有最强影响的变量。